Shifting corporate strategies on diversity, equity and inclusion, traditional journalists losing ground to influencers and ...
Anthony Olson was told that he’d die without the treatment and to ignore a negative biopsy. He’s one of many patients who may have received harmful or unnecessary treatments from Montana oncologist Dr ...
From Pfizer to AstraZeneca and the Omnicom-IPG Merger, the industry has seen a number of executive moves during this year.
Corcept’s first hypercortisolism awareness and screening campaign highlights the prevalence of what was long thought to be a very rare condition.
The healthcare technology solutions firm is saying goodbye to CEO William J. Febbo, who is leaving the company effective ...
The Biden administration hasn’t delivered on its goals of measuring the public health impact of abortion bans. Experts say it ...
The first procedure was listed as “colonoscopy and biopsy,” while the second was listed as “colonoscopy w/lesion removal.” ...
It seems simple: Require hospitals and insurers to post their negotiated prices for most health care services and — bingo — competition follows, yielding lower costs for consumers. But nearly four ...
This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback